跳至主要内容
临床试验/NCT01049646
NCT01049646已完成不适用

Interaction of Apelin and Angiotensin in the Systemic Circulation

University of Edinburgh1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
1
主要终点
Cardiac output

研究概览

简要总结

The apelin-APJ system is a relatively new discovery. It has generated interest in part due to it's apparent ability to counteract the renin-angiotensin system, which is frequently overactive in many cardiovascular disease.

Apelin improves that pumping ability of the heart and we wish to know if this action persists in the presence of increased levels of angiotensin II.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • > 18 years old
  • Healthy volunteers

排除标准

  • Lack of informed consent
  • Age < 18 years,
  • Current involvement in other research studies,
  • Systolic blood pressure >190 mmHg or <100 mmHg
  • Malignant arrhythmias
  • Renal or hepatic failure
  • Haemodynamically significant aortic stenosis
  • Severe or significant co morbidity
  • Women of childbearing potential.
  • Any regular medication
  • Previous history of any cardiovascular disease

研究组 & 干预措施

Angiotensin II

Active Comparator

干预措施: Angiotensin II (Drug)

Saline infusion

Placebo Comparator

干预措施: Saline (Drug)

结局指标

主要结局

Cardiac output

时间窗: 90 mins

次要结局

  • Systemic haemodynamics(90mins)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验